livestock animal products, together with a rise in revenues from sales of healthcare products and aesthetic innovation products for human from Baht 224.58 million in 2018 to Baht 229.87 million or 2.36% in

audit and counterbalance the operation and to prevent any transactions which may give rise to a conflict of interest, including keeping documents and evidence relating to the operation to facilitate the

audit and counterbalance the operation and to prevent any transactions which may give rise to a conflict of interest, including keeping documents and evidence relating to the operation to facilitate the

audit and counterbalance the operation and to prevent any transactions which may give rise to a conflict of interest, including keeping documents and evidence relating to the operation to facilitate the

62.51% to 57.99%. 2. Net investment revenues, gains on investments and fair value losses totally amounted to Baht 30.22 million, an increase of Baht 13.46 million, because of the rise of gains from the

(Baht 2,212 million) which was charged from the contract party, resulting in substantial rise in net profit of Q1/2010 at Baht 1,788.1 million which rose by 193.47% from the same period of 2009. Mr

(Baht 2,212 million) which was charged from the contract party, resulting in substantial rise in net profit of Q1/2010 at Baht 1,788.1 million which rose by 193.47% from the same period of 2009. Mr

million) which was charged from the contract party, resulting in substantial rise in net profit of Q1/2010 at Baht 1,788.1 million which rose by 193.47% from the same period of 2009. Mr. Choavalit as a

instruction which is a duty required to be performed. SEC Act S.300 Settlement Committee Meeting No. 5/2020 Settlement Committee Order No. 24/2020 Dated 02/09/2020

which is a duty required to be performed. SEC Act S.300 in conjunction with 56(4) Settlement Committee Meeting No. 7/2021 Settlement Committee Order No. 48/2021 Dated 21/12/2021